The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
Business Insider15 小时
Bristol Myers announces FDA approval of Opdivo Qvantig injection
Bristol Myers (BMY) Squibb announced that the U.S. FDA granted approval for Opdivo Qvantig injection for subcutaneous use, a combination product of nivolumab co-formulated with recombinant human ...
FDA approves Bristol Myers’ Opdivo Qvantig
The Food and Drug Administration announced it has approved nivolumab and hyaluronidase-nvhy, Opdivo Qvantig, from Bristol Myers (BMY) Squibb, ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” Dr. Sally Seymour ...
Business Insider3 年
A potential 'game changer' drug for weight loss and obesity was just approved by the FDA
The US Food and Drug Administration has approved a drug that could help with chronic weight management in people who are obese and overweight, the agency said in a press release on Friday.